Formulating rules for patients recovered from Covid-19: Govt
The group includes experts from New Delhi’s All India Institute of Medical Sciences, representatives from the Indian Council of Medical Research and World Health Organisation’s India office.
The Union health ministry’s technical wing is formulating guidelines to help manage long-term complications that some people have reported after recovering from severe Covid-19 illness, officials aware of the matter said.

“The ministry is working on guidelines for discharged patients who may develop other complications post-recovery at home. It has been reported that a section of recovered patients may experience respiratory or heart-related issues, renal or liver complications, or even ophthalmological (eye-related) side-effects. Our experts are working on putting a document together to guide people on what kind of long-term care would they require, and what are the issues that they may face,” said Rajesh Bhushan, an officer on special duty, the health ministry.
Click here for full Covid-19 coverage
The ministry’s technical wing, or Joint Monitoring Group (JMG), includes several domain experts. Dr Rajiv Garg, the director-general health services, chairs the group. The group includes experts from New Delhi’s All India Institute of Medical Sciences, representatives from the Indian Council of Medical Research and World Health Organisation’s India office. “This group provides an expert opinion on various topics from time to time… it has been responsible for providing technical inputs to draft guidelines on issues related to testing, isolation of patients, home isolation dos and dont’s, clinical management of Covid-19 cases in and outside hospitals…”
“My experience is that symptoms such as fever and breathlessness go away, and patients also become non-contagious after discharge, but they keep experiencing lethargy, disturbed sleep, body ache, loss of appetite, feeling feverish, and sometimes even fever that comes and goes. There is also a feeling of extreme anxiety and depression,” said Dr GC Khilnani, ex-pulmonary medicine department head at New Delhi’s AIIMS.
ABOUT THE AUTHORRhythma KaulRhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More

E-Paper


